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SUMMARY 
This study determines the frequency distribution of prominent negative symptoms in a group of 
chronic, hospitalised schizophrenics. Thirty chronic Schizophrenic (D.S.M. Ill) patients were rated on 
the scale for Assessment of Negative Symptoms (SANS) and the prominent negative symptoms were corre-
lated with age, sex and certain illness variables. Majority (80%) of patients had some or the other nega-
tive symptom, except thought blocking which was found in none. The subjective awareness of the symp-
toms was poor. Most negitive symptoms were present to a severe degree in about 40% of cases. How-
ever, no significant correlation was found between severe negative symptoms and age or sex. Similarly, 
dotation ofillness, duration of hospitalisation or current medications did not influence negative symptoms 
to any appreciable degree. The implications are discussed. 
Schizophrenia researchers have re-
cently expressed renewed interest in the 
assessment, etiology and treatment of 
negative symptoms (Andreasen, 1982; 
Andreasen and Oslen, 1982; Strauss and 
Carpenter, 1974; Crow, 1980; Lewine 
et al., 1983). Negative symptoms, defi-
ned as deficits or losses in function are 
emphasised as important features of the 
schizophrenic syndrome. They are 
common in chronic schizophrenia (And-
reasen, 1982). Current thinking about 
the phenomenology of schizophrenia stre-
sses the importance of distinguishing bet-
ween positive and negative symptoms 
(Crow, 1980; Strauss and Carpenter, 
1974). Schizophrenics presenting with 
predominant negative symptoms have 
been variously called as Negative Schi-
zophrenia (Andreasen and Oslen, 1982), 
type II Syndrome (Crow, 1980), Clinical 
Poverty Syndrome (Wing, 1978) or 
Defect State (Crow et al., 1979). These 
so-called negative or unproductive sym-
ptoms are described as typical of schi-
zophrenic deterioration (Ciompi, 1983). 
The exact etiopathogenesis of nega-
tive symptoms is unclear. Negative 
symptoms might be a consequence of 
positive symptoms that occur over exten-
ded periods, a result of social or institu-
tional responses to these symptoms or re-
latively intrinsic to the individual per-
sonality structure (Strauss and Docherty, 
1979). Biological and organic factors 
as structural brain lesions are also impli-
cated as being responsible for these nega-
tive symptoms (Johnstone et al., 1976; 
Andreasen et al., 1982; Crow, 1980). 
Social understimulation and Tnstitutiona-
lisation are other factors considered as 
influencing production of negative sy-
mptoms (Wing, 1978; Bhaskaran et al., 
1972). Or it could be a multi-deter-
mined state which occurs mainly after, 
but sometimes before the acute produc-
tive schizophrenic manifestations (Ciom-
pi, 1983). 
Preliminary research suggests nega-
tive symptoms may be useful in predic-
ting long term outcome and response 
to treatment, in distinguishing between 
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mania and schizophrenia and in identi-
fying patients with structural brain le-
sions (Andreasen, 1982; Johnstone et al., 
1976; Johnstone et al., 1978). Although 
these various studies are of interest and 
are certainly important, they raise fur-
ther questions, principally about the 
frequency of these symptoms and about 
the extent to which they are associated 
with factors as duration of illness, dura-
tion of hospitalisation and treatment 
given. 
The present study attempts to pro-
vide some new information on this im-
portant aspect. The aim is to deter-
mine the prevalence of various negative 
symptoms, in chronic hospitalised schi-
zophrenics. The second objective is to 
study the relationship between patients 
with marked or severe intensity of nega-
tive symptoms on more than two sub-
scales and certain demographic as well 
as illness variables. Such patients with 
marked negative symptoms on more than 
two sub-scales can be considered as Ne-
gative Schizophrenia (Andreasen and 
Oslen, 1982). 
MATERIAL AND METHOD 
This study was conducted at the 
National Institute of Mental Health and 
Neuro Sciences, Bangalore. Thirty pa-
tients diagnosed as Chronic Schizophre-
nia as per DSM-III (A. P. A., 1980) 
were selected at random as the sample. 
For the purpose of this study patients 
between the ages of 20 and 55 years 
and who were long stay inpatients (more 
than one year ) of this hospital were 
selected. Patients with Epliepsy, Men-
tal Retardation, Organic Mental disor-
ders and major physical diseases were 
excluded from the study. To remove 
any bias in selection, a list of cases meet-
ing the above criteria was prepared, 
from shich thirty cases were selected 
randomly. The sample consisted of 7 
males and 23 females. 
The negative symptoms in these 
patients were rated using the scale 
for Assessment of Negative Symptoms 
"SANS" (Andreasen, 1981) by two cli-
nical psychiatrists. The scale has un-
dergone tests for reliability, internal 
consistency and validation (Andreasen 
and Oslen, 1982). We have also eva-
luated the inter-rater and test-retest re-
liability of the scale and found it appli-
cable in our setting (Mathai et al., 
1984). The rating of each of the com-
ponents was made based on multiple 
sources of information including direct 
observation by the investigators and the 
nurse incharge of ward, and from re-
ports of the patients. Patients were ra-
ted on all the five sub-scales, Affective 
flattening, Alogia., Avolition-apathy, An-
hedonia -asociability and Attentional im-
pairment. For this study, patients ha-
ving marked to severe degree of the 
negative symptoms on more than two 
sub-scales, have been correlated with 
the patients' age, sex and certain illness 
variables as duration of illness, duration 
of hospitalisation and status of current 
medication. 
RESULTS 
Table I gives the distribution of the 
sample studied. The patient percentage 
distribution on various scales and sub-
scales according to severity are given in 
Table II. Majority of patients have 
some negative symptoms to be present 
definitely except blocking, which we 
found in none of our patients. The com-
mon negative symptoms are found to 
be unchanging facial expression, imper-
sistence at work, inability to feel intimacy 
and closeness and asociability in about 
80% of patients. Lack of sexual interest 
and activity and poverty of speech was 
reported in 35-40% of cases. However 
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TABLE I. Distribution of Sample  Alogia : 
Sex 
Male 
Female 
Age (in years) 
20—29 
30—39 
40—55 
Duration of Illness (in years) 
5—9 
10—15 
More than 15 
Current Medication 
Yes 
No 
7 
23 
7 
8 
15 
9 
11 
10 
21 
9 
Poverty of speech 
Poverty of content of speech 
Blocking 
Increased latency of 
Response 
Subjective rating of Alogia 
Globalrating of Alogia 
50.0 
73.3 
0.0 
40.0 
6.6 
76.6 
40.0 
63.3 
0.0 
20.0 
0.0 
53.3 
10.0 
26.6 
0.0 
0.0 
0.0 
13.3 
Amlition-Apathy : 
Grooming and Hygiene 70.0 43.3 13.3 
Impersistence at work or 
school 80.0 56.6 16.6 
Physical Anergia 73.3 46.6 16.6 
Subjective complaints of 
avolition-apathy 23.3 13.3 0.0 
Global Rating of Avolition- 80.0 46.6 23.3 
apathy 
TABLE II. Frequency of patients with var-
ying severity of negative symptoms. 
Percentage of patients 
Symptom Mode- Severe 
defini- rate Inten-
tely Inten- sity 
present sity 
Ajftctiot flattening or blunting 
Unchanging facial expre-
ssion 
Decreased spontaneous 
movements 
Paucity of Expressive 
Gestures 
80.0 
73.3 
66.6 
66.6  Poor Eye contact 
Affective Non-Re3ponsivity 70.0 
Inappropriate Affect 56.6 
Lick of vocal infections 66.6 
Subjective rating of Affec-
tive Flattening 3.0 
Globalrating 83.3 
60.0 
56.6 
46.6 
50.0 
43.3 
40.0 
30.0 
0.0 
60.0 
20.0 
13.0 
6.6 
13.3 
10.0 
16.6 
10.0 
0.0 
33.3 
Anhedonta-AssociabUity : 
Recreational interests and 
activities 76.6 56.6 10.0 
Sexual interest and acti-
vity  36.6 26.6 13.3 
Ability to feel intimacy 
and closeness 80.0 46.6 23.3 
Relationships with 
Friends & Peers 70.0 60.0 30.0 
Subjective Awareness of 
Anhedonia-Associability 16.6 13.3 0.0 
Global rating of Anhe-
donia Asociability 83.3 53.3 26.6 
Attentional Impairment : 
Work Inattentiveness 
Inattentiveness during 
Mental Status Testing 
Subjective complaints 
of Inattentiveness 
Globalrating of inatten-
tiveness 
73.3 40.0 10.0 
63.3 53.3 43.3 
3.3 0.0 0.0 
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of various negative symptoms is very 
poor in most cases. 
Twenty cases (66.7%) have mar-
ked to severe negative symptoms on mote 
than two subscales. The comparison 
between patients with negative symptoms 
on more than two subscales and those 
with minimal or absent negative symp-
toms in relation to age, sex, and certain 
illness variables are given in Table III. 
TABLE III. Negative symptoms with age, 
sex and illness 
Variable Number Negative symptoms 
of — 
Patients Absent Marked 
or to 
Minimal severe 
(n=10) (n=«20) 
Sex : 
Male 7 3 4 
Female 23 7 16 
Age (in years) 
;20— 30 7 2 5 
31—40 8 3 5 
41-55 15 5 10 
Duration of Illness (in years) 
5—10 9 4 .5 
11—15 11 2 9 
More than 15 10 4 6 
Duration of hospitalisation (in years) 
Less than 2 8 3 5 
2—5 8 2 6 
6—9 
More than 10 14 5 9 
Current Medication : 
Given 21 6 15 
Not given 9 4 5 
There is no significant statistical asso-
ciation between severe negative symp-
toms and any of the variables. 
DISCUSSION 
This report shows that a large ma-
jority (84%) of patients have definite 
negative symptoms and in about two-
thirds these were present to a marked or 
severe degree and fulfill the criteria of 
negative schizophrenia as described by 
Andreasen and Oslen (1982). None of 
the patients had any positive symptoms 
dominating the clinical picture. The 
extensive prevalence of these symptoms 
justifies the subtyping as negative schi-
zophrenia as has been done by certain 
researchers (Andreasen, 1982; Crow, 
1980). The exact frequency of negative 
symptoms in schizophrenia is not repor-
ted in literature, hence a comparison 
with the present results cannot be attemp-
ted. Symptoms like flatness of affect, 
other negative and non-specific symp-
toms were reported from all centres of 
the International Pilot Study of Schizo-
phrenia and its 2 year follow up (WHO, 
1974; WHO, 1979). Certain disabling 
negative symptoms as inattentiveness, 
inability to feel intimacy, inadequate so-
cial relations, poverty of speech and 
affective flattening present in a servere 
intensity in almost 25% of the patients 
in this study, were noticed to be present 
in many subjects in Owens and Johns-
stones (1980) study. Negative symptoms 
as apathy and withdrawal 'were difficult 
to treat in another report (Strauss and 
£)ocherty, 1979). 
Interestingly, there is no signifi-
cant correlation between negative schi-
zophrenia and age or sex. Bhaskaran 
et al., (1972) reported more severe defi-
cits in females and positive relationship 
between age and deficits was reported 
by Owens and Johnstone (1980) and 
Johnstone et al., (1981). The difference 204  S. K. CHATURVEDI et <d. 
is probably due to the nature of the sam-
ple, Owens and Johnstone examined 
mainly elderly patients with mean age 
60 years. Similarly, duration of illness 
and duration of hospitalisation have no 
significant association with severe nega-
tive symptoms in this study as was noti-
ced by Bhaskaran et al. (1972) also. 
Some clinicians believe that negative 
symptoms increase as illness becomes 
more chronic (Strauss and Docherty, 
1979; Johnstone et al., 1981) and some 
implicate hospitalisation and hospital 
environment to be responsible for caus-
ing deficits and negative symptoms as 
avolition or apathy (Wing and Brown, 
1961; Wing and Brown, 1970; Bhaska-
ran, 1970; Bhaskaran et al., 1972; Strauss 
and Docherty, 1979). The present study 
does not lend support to this opinion as 
there is no significant differential distri-
bution of patients with negative schi-
zophrenia in relation to duration of 
illness of hospitalisation. Similar results 
were reported by Andreasen and Oslen 
(1982). 
The role of continuing medications 
in chronic schizoprenics has been a 
controversial area. Some surveys found 
no difference of outcome between pati-
ents discontinuing medications and those 
-ontinuing (Johnson, 1976, Johnson, 
1979; Johnson et al., 1983). Andreasen 
and Oslen (1982), Wing and Brown 
(1970) and Owens and Johnstone (1980) 
reported that neuroleptic medication as 
such does not contribute to development 
of deficits or negative symptoms. This 
study also has found no difference in 
severity of negative symptoms between 
patients continuing or not continuing 
medications. These patients were not 
on any medication for more than two 
years as the clinical status, had been 
stable and the symptoms were not show-
ing even slightest improvement. Other 
patients were receiving long term depot 
preparations (Fluphenazine decanoate). 
Probably, additional investigation is 
required to determine the frequency of 
negative symptoms in a relatively lar-
ger sample of schizophrenic patients, 
their possible predictive validity and 
possible remedial measures. This study 
certainly proves that negative symptoms 
are very common in chronic schizophre-
nia as was reported by Andreasen (1982) 
also. Also, it makes clearer the absence 
of role of duration of illness, hospitali-
sation, medication, age or sex in produ-
cing negative symptoms. The area of 
reseaich is interesting and more work 
from the Indian Culture and background 
as well as cross-cultural studies would 
prove to be illuminative. 
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